Specific chimeric antigen receptor cell armed with targeted CXCR2 ligand as well as preparation method and application thereof
The invention relates to a specific chimeric antigen receptor cell armed with a targeted CXCR2 ligand as well as a preparation method and application thereof. Through a method, which uses a recombinant carrier of a chimeric antigen receptor that specifically targets human NKG2DL armed with a targeti...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a specific chimeric antigen receptor cell armed with a targeted CXCR2 ligand as well as a preparation method and application thereof. Through a method, which uses a recombinant carrier of a chimeric antigen receptor that specifically targets human NKG2DL armed with a targeting CXCR2 ligand to modify a immune response cell, the obtained novel functionalized immune responsecell can effectively attack multiple tumors in a targeted mode; and the functionalized immune response cell can be used to prepare preparations for treating malignant tumors. The engineering immune cells modified by a chimeric antigen receptor that is armed with a targeting CXCR2 ligand and specifically targets human NKG2DL can more easily migrate to a tumor position and continuously kill the tumors in a targeted mode.
本发明涉及一种武装靶向CXCR2配体的特异性嵌合抗原受体细胞及其制备方法和应用。本发明通过武装靶向CXCR2配体的特异性靶向人NKG2DL的嵌合抗原受体的重组载体,并用其修饰免疫应答细胞的方法;获得的新型功能化免疫应答细胞能有效地靶向攻击多种肿瘤,及制备的用于治疗恶性肿瘤的制剂。本发明的武装靶向CXCR2配体的特异性靶向人NKG2DL的嵌合抗原受体修饰的工程免疫细胞更加容易迁移至肿瘤部位,持续靶向杀伤 |
---|